Renato Leonardo de Freitas Selected Research

naloxonazine

12/2016	µ1 -Opioid receptors in the dorsomedial and ventrolateral columns of the periaqueductal grey matter are critical for the enhancement of post-ictal antinociception.
2/2012	Endogenous opioid peptide-mediated neurotransmission in central and pericentral nuclei of the inferior colliculus recruits μ1-opioid receptor to modulate post-ictal antinociception.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renato Leonardo de Freitas Research Topics

Disease

7	Hyperalgesia 12/2023 - 09/2019
7	Neuralgia (Stump Neuralgia) 12/2023 - 09/2019
7	Seizures (Absence Seizure) 12/2016 - 10/2004
3	Pain (Aches) 01/2014 - 04/2012
2	Panic Disorder (Panic Attack) 01/2019 - 06/2014
1	Schizophrenia (Dementia Praecox) 12/2023
1	Epilepsy (Aura) 10/2004

Drug/Important Bio-Agent (IBA)

6	N-Methylaspartate (NMDA)IBA 12/2023 - 06/2014
3	AcetoneIBA 12/2023 - 07/2023
3	gamma-Aminobutyric Acid (GABA)IBA 12/2016 - 10/2004
3	Pentylenetetrazole (Metrazol)IBA 12/2016 - 10/2004
2	salicylhydroxamic acid (SHAM)IBA 12/2023 - 12/2023
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2021 - 09/2019
2	LY 235959IBA 10/2021 - 09/2019
2	Opioid Receptors (Opioid Receptor)IBA 01/2019 - 12/2016
2	Opioid Peptides (Opioid Peptide)IBA 01/2019 - 04/2012
2	naloxonazineIBA 12/2016 - 02/2012
2	Aminobutyrates (Aminobutyric Acid)IBA 11/2016 - 06/2014
2	cobaltous chloride (cobalt(II)chloride)IBA 01/2014 - 05/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2014 - 04/2013
2	Cholinergic Agents (Cholinergics)IBA 05/2013 - 10/2004
2	Cholinergic ReceptorsIBA 05/2013 - 10/2004
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2013 - 10/2011
1	Haloperidol (Haldol)FDA LinkGeneric 12/2023
1	Antipsychotic Agents (Antipsychotics)IBA 12/2023
1	N1,N8- bis(2,5- dihydroxybenzoyl)spermidineIBA 07/2023
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2020
1	TRPV1 receptorIBA 12/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2019
1	Naloxone (Narcan)FDA LinkGeneric 01/2019
1	Narcotic Antagonists (Opioid Antagonists)IBA 12/2016
1	Naltrexone (ReVia)FDA LinkGeneric 12/2016
1	Opioid Analgesics (Opioids)IBA 11/2016
1	IonophoresIBA 11/2016
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 06/2014
1	Kainic Acid Receptors (Kainate Receptor)IBA 06/2014
1	Atropine FDA LinkGeneric 05/2013
1	MecamylamineIBA 05/2013
1	Dimenhydrinate (DMH)FDA LinkGeneric 04/2013
1	Sucrose (Saccharose)IBA 04/2012

Therapy/Procedure

2	Therapeutics 12/2023 - 10/2021
2	Ligation 01/2021 - 01/2020
2	Analgesia 05/2013 - 10/2004